Research Billerbeck Group
We use a combination of synthetic biology, genome engineering, protein engineering and environmental microbiology to access, understand and engineer the functional diversity of nature’s yeast-based mycobiome for applications in human health, industrial biotechnology and to answer fundamental questions on yeast (pathogen) biology.
We are interested in understanding and engineering both, industrially relevant yeasts such as wild isolates of Saccharomyces cerevisiae as well as yeast-based human fungal pathogens such as Candida glabrata, Candida albicans and Candida auris.
Our overarching goal is to deliver new knowledge, innovative ideas, proof-of-concepts and products that generate bio-based solutions for global challenges.
WE CURRENTLY FOCUS ON THE CHALLENGE OF TACKLING DRUG-RESISTANT PATHOGENIC FUNGI.
For more information please visit the website.
|Last modified:||28 April 2020 12.20 p.m.|